Physician profile
Nuzhat Moinuddin
NPI 1730890377
$989.26
in general payments reported to CMS, 2019-2025
4 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.28 · 2023: $51.06 · 2024: $508 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Travel and Lodging: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.13 |
| Travel and Lodging | $205.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $688.93 | 2023-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Saluda Medical Americas, INC. | $242.42 | 2024-2025 | Evoke |
| Fidia Pharma USA INC. | $32.63 | 2023 | Hymovis, Triluron |
| Relievant Medsystems, INC. | $25.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nuzhat Moinuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.